Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$57.01

0.94 (1.68%)

, INFO

IHS Markit

$47.60

0.17 (0.36%)

04:55
02/27/18
02/27
04:55
02/27/18
04:55

National Association for Business Economics to hold a conference

34th Annual NABE Economic Policy Conference will be held in Washington, D.C. on February 25-27.

MS

Morgan Stanley

$57.01

0.94 (1.68%)

INFO

IHS Markit

$47.60

0.17 (0.36%)

DB

Deutsche Bank

$16.48

0.05 (0.30%)

NTRS

Northern Trust

$108.84

2.28 (2.14%)

SO

Southern Company

$44.03

-0.04 (-0.09%)

F

Ford

$10.89

0.19 (1.78%)

C

Citi

$77.65

0.57 (0.74%)

CX

Cemex

$6.96

-0.13 (-1.83%)

FNMA

Fannie Mae

$1.72

-0.035 (-2.00%)

WFC

Wells Fargo

$59.97

0.8 (1.35%)

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 06

    Mar

  • 07

    Mar

  • 12

    Mar

  • 13

    Mar

  • 15

    Mar

  • 30

    May

MS Morgan Stanley
$57.01

0.94 (1.68%)

01/10/18
01/10/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Neutral from Underweight at Atlantic Equities by analyst John Heagerty, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Wells Fargo shares to $64 from $55. The analyst also upgraded Morgan Stanley (MS) to Overweight this morning, citing the same analysis of the potential benefits from tax reform. 2. Deere upgraded to Outperform from Sector Perform at RBC Capital by analyst Seth Weber, who said he is positive on the company's leadership position in North American farm machinery which is stabilizing and exposure to the earth moving equipment category. The analyst is also constructive on Deere's recent Wirten Group acquisition. 3. Target (TGT) upgraded to Positive from Neutral at Susquehanna. 4. State Street (STT) and BNY Mellon (BK) upgraded to Buy from Neutral at Citi, with analyst Keith Horowitz saying he thinks the trust banks are the best way to play the digital transformation to the cloud and finds the current valuation as attractive. 5. RBS (RBS) upgraded to Overweight from Equal Weight at Morgan Stanley. Analyst Alvaro Serrano also downgraded Barclays (BCS) and Lloyds Banking (LYG). This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/10/18
ATLE
01/10/18
UPGRADE
Target $61
ATLE
Overweight
Morgan Stanley upgraded on tax reform benefits at Atlantic Equities
As previously reported, Atlantic Equities analyst John Heagerty upgraded Morgan Stanley (MS) to Overweight from Neutral, as his analysis leads him to increase his FY18 EPS view by 11% on average for the banks he covers. He also sees positive secondary effects for the banks from higher U.S. GDP growth. Heagerty raised his price target on Morgan Stanley shares to $61 from $48. The analyst also upgraded Wells Fargo (WFC) to Neutral from Underweight this morning, citing the same analysis of the potential benefits from tax reform.
01/10/18
ATLE
01/10/18
UPGRADE
ATLE
Overweight
Morgan Stanley upgraded to Overweight from Neutral at Atlantic Equities
01/09/18
SOCG
01/09/18
DOWNGRADE
Target $59.5
SOCG
Hold
Morgan Stanley downgraded to Hold from Buy at Societe Generale
Societe Generale analyst Andrew Lim downgraded Morgan Stanley to Hold saying the stock is now fairly priced following the recent rally. The analyst raised his price target for the shares to $59.50 from $55.
INFO IHS Markit
$47.60

0.17 (0.36%)

02/01/18
WBLR
02/01/18
UPGRADE
WBLR
Outperform
IHS Markit upgraded to Outperform from Market Perform at William Blair
11/28/17
RHCO
11/28/17
UPGRADE
RHCO
Buy
IHS Markit upgraded to Buy from Hold at SunTrust
11/28/17
RHCO
11/28/17
UPGRADE
Target $52
RHCO
Buy
IHS Markit upgraded to Buy at SunTrust on strong Resources and Transportation
As reported earlier, SunTrust analyst Andrew Jeffrey upgraded IHS Markit to Buy from Hold and raised his price target to $52 from $48. Jeffrey says his "non-consensus view" is based on increased expectations of faster organic revenue growth due to recovery in Resources and further strength in Transportation. The analyst is also positive on the company's new products, geographic expansion and Used market resilience countering potential cyclical pullback in the Auto market.
02/02/18
WBLR
02/02/18
UPGRADE
WBLR
Outperform
IHS Markit upgraded to Outperform from Market Perform at William Blair
William Blair analyst Timothy McHugh last night upgraded IHS Markit to Outperform from Market Perform after assuming coverage from Brandon Dobell. The analyst sees upside to the company's guidance from favorable currency exchange rates. He believes IHS Markit will continue to exceed revenue projections.
DB Deutsche Bank
$16.48

0.05 (0.30%)

11/20/17
KBWI
11/20/17
DOWNGRADE
KBWI
Underperform
Deutsche Bank downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst George Karamanos downgraded Deutsche Bank to Underperform.
02/14/18
02/14/18
DOWNGRADE
Target $48

Hold
Luxoft downgraded to Hold on 'elongated turnaround' at Pivotal Research
As previously reported, Pivotal Research analyst Lou Miscioscia downgraded Luxoft (LXFT) to Hold from Buy, as he now expects most of FY19 to be "a struggle." He had expected the company's two biggest customers - namely Deutsche Bank (DB) and UBS (UBS) - to be about flat for FY19, but now they are suggested to be down 20% and 5%, respectively, Miscioscia said. Noting also that the company cut its FY18 guidance along with its Q3 report, the analyst lowered his price target on Luxoft to $48 from $70.
02/19/18
BOFA
02/19/18
UPGRADE
BOFA
Neutral
Deutsche Bank upgraded to Neutral from Underperform at BofA/Merrill
11/20/17
11/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler sayign valuation following "powerful" share appreciation now reflects the company's progress in growing earnings. 2. Five Below (FIVE) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation. 3. Live Nation (LYV) downgraded to In Line from Outperform at Evercore ISI with analyst David Joyce citing valuation. 4. Monster Beverage (MNST) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing its high valuation, which he believes is misplaced due to assumptions about an offer from Coca-Cola (KO). 5. Deutsche Bank (DB) downgraded to Underperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NTRS Northern Trust
$108.84

2.28 (2.14%)

12/20/17
WELS
12/20/17
NO CHANGE
Target $105
WELS
Market Perform
Northern Trust price target raised to $105 from $95 at Wells Fargo
Wells Fargo analyst Mike Mayo raised his price target for Northern Trust to $105 from $95 to reflect more potential upside from a portion of higher interest rates, lower taxes, and lower cost of capital due to greater resiliency. The analyst reiterates a Market Perform rating on the shares.
08/09/17
WELS
08/09/17
INITIATION
Target $90
WELS
Market Perform
Northern Trust initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo started Northern Trust with a Market Perform rating and $90 price target.
01/25/18
RBCM
01/25/18
NO CHANGE
Target $110
RBCM
Outperform
Northern Trust price target raised to $110 from $97 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Northern Trust to $110 and kept his Outperform rating after Q4 results that were supported by strength in C&IS business, wealth management, and net interest income. The analyst adds that the company's capital levels are "robust" as it remains committed to returning excess capital to shareholders.
09/08/17
UBSW
09/08/17
UPGRADE
UBSW
Buy
Northern Trust upgraded to Buy from Neutral at UBS
SO Southern Company
$44.03

-0.04 (-0.09%)

01/12/18
JPMS
01/12/18
INITIATION
Target $46
JPMS
Underweight
Southern Company initiated with an Underweight at JPMorgan
JPMorgan analyst Christopher Turnure started Southern Company with an Underweight rating and $46 price target. The analyst sees limited visibility moving forward on construction and regulatory execution for the Vogtle project. He expects the company's updated long-term earnings growth outlook to disappoint.
01/23/18
01/23/18
DOWNGRADE
Target $44.5

Neutral
Southern Company downgraded to Neutral at Mizuho
As previously reported, Mizuho downgraded Southern Company to Neutral from Buy and cut its price target to $44.50 from $52. Analyst Paul Fremont expects Southern will need need incremental equity through 2020 to offset incremental downward pressure on credit metrics resulting from higher recent debt balances and the impact from tax reform.
01/23/18
MZHO
01/23/18
DOWNGRADE
MZHO
Neutral
Southern Company downgraded to Neutral from Buy at Mizuho
02/02/18
UBSW
02/02/18
INITIATION
Target $46
UBSW
Neutral
Southern Company initiated with a Neutral at UBS
UBS analyst Daniel Ford started Southern Company with a Neutral rating and $46 price target.
F Ford
$10.89

0.19 (1.78%)

02/01/18
NOMU
02/01/18
NO CHANGE
Target $11
NOMU
Neutral
Ford price target lowered to $11 from $12.80 at Nomura Instinet
Nomura Instinet analyst Anindya Das lowered his price target for Ford to $11 following a review of the company's Q4 results. The analyst now factors in a more adverse year-over-year headwind from commodity costs in 2018. He keeps a Neutral rating on Ford.
12/28/17
MSCO
12/28/17
NO CHANGE
MSCO
January to be busy for Autos and Shared Mobility names, says Morgan Stanley
Morgan Stanley analyst Adam Jonas previewed the January calendar for the Autos and Shared Mobility sector, noting that the Vegas CES takes place in the second week and the Detroit Auto Show occurs in the third week of next month. Judging from last year's shows and press releases in recent weeks, he expects "the vast majority" of prepared presentations will focus on autonomous driving, electric propulsion and new business models as companies seek to encourage recognition and valuation of "Auto 2.0 efforts" in the multiples of their stocks, he tells investors. Automakers covered by the firm include Fiat Chrysler (FCAU), Tesla (TSLA), General Motors (GM), Ferrari (RACE) and Ford (F). Auto suppliers covered include Magna (MGA), Goodyear Tire (GT), Adient (ADNT), Delphi Technologies (DLPH), Visteon (VC), BorgWarner (BWA), Aptiv (APTV) and Tenneco (TEN).
10/31/17
MSCO
10/31/17
NO CHANGE
Target $10
MSCO
Underweight
Ford bull case view raised despite 'significant headwinds' at Morgan Stanley
Morgan Stanley analyst Adam Jonas raised his 2017 EPS estimate for Ford to near the midpoint of the company's guidance following its Q3 report and slightly increased his price target on the stock to $10 from $9. While he keeps an Underweight rating on Ford, stating that the headwinds it faces are significant, he also sees the "scope for an equally significant response" and raised his bull case to $25 from $18 given a sum-of-the-parts analysis under which he values Ford's truck business, including the F-series and others, at nearly $20 per share, Ford Europe, S. America and Asia Pacific at "slightly less than zero" and "Ford Future" at $3B, or 74c per Ford share.
12/21/17
OPCO
12/21/17
NO CHANGE
Target $9
OPCO
Outperform
TeleNav extension with Ford should remove overhang, says Oppenheimer
Craig-Hallum analyst Steven Dyer notes that TeleNav (TNAV) announced preliminary Q2 results and amended its current agreement with Ford (F), which he believes is net/net positive for the P&L and should be a catalyst for shares. The analyst thinks the extension with Ford removes a major overhang on shares as it provides visibility for the next three years. Dyer reiterates an Outperform rating on TeleNav's shares, while lowering his price target on the stock to $9 from $12.
C Citi
$77.65

0.57 (0.74%)

01/17/18
VERF
01/17/18
DOWNGRADE
VERF
Hold
Citi downgraded to Hold from Buy at Vertical Group
02/02/18
MSCO
02/02/18
NO CHANGE
MSCO
BofA, JPMorgan, Citi best positioned for tougher CCAR test, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck said she had expected an easier stress test from the Federal Reserve but that the 2018 CCAR test actually seems tougher than last year, given the more intense recessions and lower asset prices modeled in it. A tougher test makes her less optimistic on her strong payout growth expectations, said Graseck, who sees Bank of America (BAC), JPMorgan (JPM) and Citi (C) as best positioned to "weather the storm" and increase payouts given their resilient balance sheets and significant excess capital. She sees Goldman Sachs (GS), which recently cut buybacks, as at risk from a tougher test, which likely weighs on the bank's 2018 ask, Graseck added.
01/17/18
01/17/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Longbow with analyst Shawn Harrison saying the current iPhone cycle is "good, not great." 2. Dish (DISH) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benjamin Swinburne saying he now sees fewer likely buyers of its assets than hoped. 3. Juniper (JNPR) downgraded to Underweight from Equal Weight at Barclays with analyst Mark Moskowitz citing a lack of service provider rebound in 2018 as well as a rising threat from Arista in routing. 4. Citi (C) was downgraded to Hold from Buy at Vertical Group and to Market Perform from Outperform at Keefe Bruyette. 5. Shell Midstream (SHLX) downgraded to Hold from Buy at Stifel with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/18
RBCM
01/17/18
NO CHANGE
Target $85
RBCM
Outperform
Citi price target raised to $85 from $79 at RBC Capital
RBC Capital analyst Gerard Cassidy raised his price target on Citi to $85 and kept his Outperform rating following Q4 earnings. Cassidy says that non-cash charges from tax reform masked the quarter's performance, with underlying trends for Citi remaining strong. The analyst adds that CitiGroup importantly reiterated the $60B capital return goal through CCAR despite the regulatory capital hit from the tax legislation.
CX Cemex
$6.96

-0.13 (-1.83%)

02/15/18
UBSW
02/15/18
DOWNGRADE
Target $6.5
UBSW
Sell
Cemex downgraded to Sell from Buy at UBS
UBS analyst Mauricio Serna double downgraded Cemex to Sell from Buy and cut his price target for the shares to $6.50 from $10.20. The analyst expects the share selloff to continue given the company's "struggling" international operations and "still high" debt. Seeking approval for 25% equity capital issuance for potential acquisitions adds uncertainty when Cemex is losing market share and has eroding margins, Serna tells investors in a research note. He reduced his estimates for the company "significantly."
02/15/18
02/15/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alaska Air (ALK) downgraded to Neutral from Buy at UBS with analyst Darryl Genovesi saying he believes consensus estimates are too high and in particular reflect too rosy a RASM view given progressively more intense competition in its network. 2. Patterson Companies (PDCO) downgraded to Underweight from Neutral at JPMorgan with analyst Michael Minchak saying the company faces more near-term headwinds and uncertainties relative to other names he covers. He believes it will take time for Patterson's initiatives to bear fruit. 3. Cemex (CX) downgraded to Sell from Buy at UBS with analyst Mauricio Serna says he expects the share selloff to continue given the company's "struggling" international operations and "still high" debt. 4. Atara Biotherapeutics (ATRA) downgraded to Sell from Neutral at Citi with analyst Yigal Nochomovitz saying the recent 200%-plus rally in the shares is not supported by fundamentals. 5. Tanger Factory (SKT) downgraded to Underperform from In Line at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/17
SBSH
12/19/17
UPGRADE
Target $10
SBSH
Buy
Cemex upgraded to Buy from Neutral at Citi
Citi analyst Dan McGoey upgraded Cemex to Buy and raised his price target for the shares to $10 from $9.20. The analyst sees a "compelling valuation" following the recent pullback in the shares. Further, the analyst is "incrementally positive" on the company's major markets following recent meetings.
12/19/17
SANT
12/19/17
DOWNGRADE
SANT
Hold
Cemex downgraded to Hold from Buy at Santander
FNMA Fannie Mae
$1.72

-0.035 (-2.00%)

06/15/17
WEDB
06/15/17
UPGRADE
WEDB
Outperform
Beazer Homes upgraded on loosening credit standards at Wedbush
As noted earlier, Wedbush upgraded Beazer Homes (BZH) to Outperform from Neutral. Analyst Jay McCanless upgraded the stock based on what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." The analyst says that Beazer focuses on "entry level consumers who..benefit most from lower lending standards." Target remains $15.
12/22/17
KBWI
12/22/17
NO CHANGE
KBWI
Keefe Bruyette keeps $1 price targets on Fannie and Freddie
The Federal Housing Finance Agency, as conservator of Fannie Mae (FNMA) and Freddie Mac (FMCC), and the Department of the Treasury agreed to reinstate a $3B capital reserve amount under the Senior Preferred Stock Purchase Agreements for each of the companies beginning in Q4, Keefe Bruyette analyst Bose George told investors last night in a research note. The government-sponsored enterprises are still expected to incur deferred tax asset write-downs if the corporate tax rate falls to 21% from the current 35%, George points out. He estimates that the write-down will be $12B for Fannie Mae and $7B for Freddie Mac. The analyst does not see the reinstatement of the capital buffer as a change in policy towards the GSEs. As such, George makes no changes to his outlook on the shares and keeps Underperform ratings on both Fannie and Freddie with $1 price targets. Fannie is down 2% to $2.78 while Freddie is down 3% to $2.60 in morning trading.
WFC Wells Fargo
$59.97

0.8 (1.35%)

02/21/18
MSCO
02/21/18
NO CHANGE
Target $136
MSCO
Overweight
Morgan Stanley sees JPMorgan turning tax savings into market share gains
Morgan Stanley analyst Betsy Graseck raised her 2022 EPS estimate for JPMorgan (JPM) by 2%, or 34c, stating that she expects the bank to reach top 5 in the 15-20 new markets it previously said it will use a part of its tax savings reinvestments to enter. The 34c in EPS she estimates JPMorgan can add by building out its presence in 20 new markets by 2022 is "far more compelling" than using the same amount of money to buy back stock, which would increase 2022 EPS only 5c, said Graseck. The analyst sees about a third of JPMorgan's new deposit share gains to come from Wells Fargo (WFC) and cut her 2022 EPS forecast for the latter by 1.2%. Graseck keeps an Overweight rating on JPMorgan ahead of the bank's February 27 investor day and increased her price target on the stock to $136 from $133.
02/05/18
02/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Market Perform from Outperform at Keefe Bruyette, to Neutral from Buy at Citi, to Underperform from Outperform at RBC Capital, to Underweight from Neutral at JPMorgan, and two notches to Underweight from Overweight at Morgan Stanley. 2. Dick's Sporting (DKS) downgraded to Underweight from Equal Weight at Barclays with analyst Matthew McClintock saying sentiment on the shares have improved over the past month under the narrative that Dick's could become the next Best Buy (BBY). 3. Amgen (AMGN) downgraded to Neutral from Overweight at Atlantic Equities with analyst Steve Chesney citing relative valuation and more balanced risk/reward on Repatha's commercial trajectory and the of legacy biologics given biosimilar, branded and IP risks. 4. Marathon Petroleum (MPC) and MPLX (MPLX) were downgraded to Hold from Buy at Jefferies. 5. VMware (VMW) downgraded to Neutral from Buy at Citi with analyst Walter Pritchard saying he sees "no easy deal" for Dell and expects the overhang to cap VMware shares around the $138 level. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/05/18
UBSW
02/05/18
NO CHANGE
Target $63
UBSW
Neutral
Wells Fargo consent order a material setback, says UBS
UBS analyst Saul Martinez views Wells Fargo's consent order as a material setback, as the company will be unable to grow its assets until the Fed approves plans to improve board oversight and governance and overall compliance and operational risk management. Martinez maintained his Neutral rating and $63 price target on Wells Fargo shares.
02/05/18
RBCM
02/05/18
DOWNGRADE
RBCM
Underperform
Wells Fargo downgraded to Underperform at RBC Capital after Fed action
As reported earlier, RBC Capital analyst Gerard Cassidy downgraded Wells Fargo two notches to Underperform from Outperform and cut his price target to $50 from $65. Cassidy cites the latest regulatory action against the bank by the Fed which prohibits its balance sheet from growing. The analyst notes that he was surprised by the Fed's Cease and Desist Order given the investment made by the bank to remedy its sales practices issues.

TODAY'S FREE FLY STORIES

02:20
07/18/18
07/18
02:20
07/18/18
02:20
General news
FX Update: The dollar has traded firmer for a second day »

FX Update: The dollar…

01:50
07/18/18
07/18
01:50
07/18/18
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

CCB

Coastal Financial

$0.00

(0.00%)

21:11
07/17/18
07/17
21:11
07/17/18
21:11
Syndicate
Coastal Financial 2.85M share IPO priced at $14.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CRNX

Crinetics

$0.00

(0.00%)

21:08
07/17/18
07/17
21:08
07/17/18
21:08
Syndicate
Crinetics 6M share IPO priced at $17.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

NSTG

NanoString

$12.74

-2.36 (-15.63%)

21:07
07/17/18
07/17
21:07
07/17/18
21:07
Syndicate
NanoString 4M share Secondary priced at $12.50 »

JPMorgan and UBS acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 18

    Jul

ALV

Autoliv

$106.86

1.57 (1.49%)

21:06
07/17/18
07/17
21:06
07/17/18
21:06
Downgrade
Autoliv rating change at Wells Fargo »

Autoliv downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$131.71

3.58 (2.79%)

21:06
07/17/18
07/17
21:06
07/17/18
21:06
Downgrade
Visteon rating change at Wells Fargo »

Visteon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

ABT

Abbott

$62.84

1.05 (1.70%)

, MS

Morgan Stanley

$49.20

0.29 (0.59%)

20:25
07/17/18
07/17
20:25
07/17/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$62.84

1.05 (1.70%)

MS

Morgan Stanley

$49.20

0.29 (0.59%)

USB

U.S. Bancorp

$51.29

-0.01 (-0.02%)

TXT

Textron

$66.81

0.14 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

ADTN

Adtran

$16.05

0.1 (0.63%)

20:14
07/17/18
07/17
20:14
07/17/18
20:14
Earnings
Adtran reports Q2 adjusted EPS (10c), two estimates (32c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

, ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

20:09
07/17/18
07/17
20:09
07/17/18
20:09
Hot Stocks
FS Bancorp to merge with Anchor Bancorp in $77M deal »

FS Bancorp (FSBW) and…

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.41

-1.19 (-4.31%)

20:06
07/17/18
07/17
20:06
07/17/18
20:06
Hot Stocks
Breaking Hot Stocks news story on Canopy Growth  »

Greenstar Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$356.95

0.94 (0.26%)

19:10
07/17/18
07/17
19:10
07/17/18
19:10
Hot Stocks
Boeing awarded $3.9B government contract »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MRTN

Marten Transport

$22.10

(0.00%)

, UAL

United Continental

$72.66

0.38 (0.53%)

19:03
07/17/18
07/17
19:03
07/17/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Martin…

MRTN

Marten Transport

$22.10

(0.00%)

UAL

United Continental

$72.66

0.38 (0.53%)

CSX

CSX

$64.42

0.46 (0.72%)

MLNX

Mellanox

$84.85

0.9 (1.07%)

IBKR

Interactive Brokers

$64.65

1.93 (3.08%)

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

TXN

Texas Instruments

$115.80

1.21 (1.06%)

SAH

Sonic Automotive

$20.45

0.3 (1.49%)

CARA

Cara Therapeutics

$21.60

0.435 (2.06%)

CASI

Casi Pharmaceuticals

$7.26

-0.215 (-2.88%)

TLYS

Tilly's

$15.35

0.21 (1.39%)

CLX

Clorox

$135.00

0.71 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 02

    Aug

  • 26

    Aug

  • 19

    Jul

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:38
07/17/18
07/17
18:38
07/17/18
18:38
Hot Stocks
BHP Billiton sees FY19 copper equivalent output broadly in line with FY18 »

Says expects to achieve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:35
07/17/18
07/17
18:35
07/17/18
18:35
Hot Stocks
BHP Billiton reports Q4 petroleum production 49 MMBOE, down 6% »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$135.00

0.71 (0.53%)

18:31
07/17/18
07/17
18:31
07/17/18
18:31
Downgrade
Clorox rating change at Goldman Sachs »

Clorox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

NCS

NCI Building

$20.70

0.15 (0.73%)

18:27
07/17/18
07/17
18:27
07/17/18
18:27
Hot Stocks
NCI Building Systems, Ply Gem Parent to combine in stock-for-stock merger »

NCI Building Systems and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

, AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

18:16
07/17/18
07/17
18:16
07/17/18
18:16
Earnings
America Movil reports Q2 operating profit MXN32.6M, up 4.8% from last year »

Reports Q2 revenue…

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,844.00

21.98 (1.21%)

18:08
07/17/18
07/17
18:08
07/17/18
18:08
Recommendations
Amazon.com analyst commentary at Piper Jaffray »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

, BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

18:06
07/17/18
07/17
18:06
07/17/18
18:06
Hot Stocks
Berkshire Hathaway amends share repurchase program »

The Board of Directors of…

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$60.10

-0.5 (-0.83%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Earnings
Pinnacle Financial reports Q2 EPS $1.15, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Sep

CHDN

Churchill Downs

$304.60

1.1 (0.36%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Hot Stocks
Churchill Downs receives approval to increase historical racing machines »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CE

Celanese

$110.22

1.6 (1.47%)

18:01
07/17/18
07/17
18:01
07/17/18
18:01
Hot Stocks
Celanese announces acetic acid price increases in Asia »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BLK

BlackRock

$504.89

1.14 (0.23%)

17:51
07/17/18
07/17
17:51
07/17/18
17:51
Hot Stocks
BlackRock raises quarterly dividend to $3.13 from $2.88 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRNA

Dicerna

$12.47

0.57 (4.79%)

17:45
07/17/18
07/17
17:45
07/17/18
17:45
Conference/Events
Dicerna management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.